BDB-001 Phase III Trial in ANCA-Associated Vasculitis
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Recruiting · NCT07168161 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BDB-001 Phase III Trial in ANCA-Associated Vasculitis | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, immune system disorder, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 3 | 2026-08-13 | NCT07168161 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Staidson (Beijing) Biopharmaceuticals Co., Ltd | 5 |
64 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.